
Mounjaro vs Saxenda: 22.5% vs 8% — Which Injection to Choose in 2026
Comparing two GLP-1 products: Mounjaro delivers 22.5% weight loss once weekly, Saxenda — 8% daily. Complete analysis of effectiveness, side effects and cost.
Expert articles on effective weight loss, Mounjaro, and peptides
133 articles

Comparing two GLP-1 products: Mounjaro delivers 22.5% weight loss once weekly, Saxenda — 8% daily. Complete analysis of effectiveness, side effects and cost.

7 GLP-1 medications in one table: Mounjaro, Ozempic, Wegovy, Saxenda, Rybelsus, Biopatid, Retatrutide. Mechanism, effectiveness, price, availability in Ukraine.

Weight loss stalled on Mounjaro or Ozempic? It's normal. 7 specific strategies from DOZA specialists: from dose adjustment to peptide boosters.

Studies show: 60% of lost weight returns within a year after stopping GLP-1. But this isn't a sentence. We explain exit strategies and maintenance therapy.

Complete Ozempic dosage table: 0.25 mg → 0.5 mg → 1.0 mg. When to increase, what to do if you miss a dose, and comparison with Mounjaro.

Complete nutrition guide for those taking Mounjaro or Ozempic: which foods to choose, how to manage reduced appetite, and get enough protein.
Ready to lose weight with Mounjaro?
Free specialist consultation — we'll select the right dose and program for you

Realistic Ozempic weight loss results from STEP trials: -11 lbs in 3 months, -31 lbs in 1 year. Monthly timeline and when Ozempic outperforms Mounjaro.

Concrete numbers from SURMOUNT clinical trials: how much weight you can realistically lose on Mounjaro depending on dose and starting weight — science, not marketing.

Analyzing Mounjaro (tirzepatide) safety based on real clinical studies: heart, pancreatitis, thyroid. Facts from DOZA without panic.

Which Mounjaro dose to choose? Table of all 6 dosages with KwikPen markings, escalation schedule every 4 weeks, and what to do with side effects.

Tirzepatide activates two hormonal receptors instead of one. Result — record-breaking -22.5% weight loss in clinical trials. Why does this work better than everything else?

Semaglutide is a synthetic GLP-1 hormone analogue developed by Novo Nordisk. STEP-1 study results showed -14.9% weight loss, while SELECT proved 20% reduction in cardiovascular events. Learn how this molecule works, the differences between Ozempic, Wegovy and Rybelsus brands, and how semaglutide compares to tirzepatide.